Cargando…
Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial
Aims: Deprescribing of antihypertensive drugs is recommended for some older patients with polypharmacy, but there is little evidence to inform which drug (or dose) should be withdrawn. This study used data from the OPTiMISE trial to examine whether short-term outcomes of deprescribing vary by drug c...
Autores principales: | Sheppard, James P., Lown, Mark, Burt, Jenni, Ford, Gary A., Hobbs, F. D. Richard, Little, Paul, Mant, Jonathan, Payne, Rupert A., McManus, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093867/ https://www.ncbi.nlm.nih.gov/pubmed/33959004 http://dx.doi.org/10.3389/fphar.2021.619088 |
Ejemplares similares
-
Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial
por: Jowett, Sue, et al.
Publicado: (2022) -
OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial
por: Sheppard, James P, et al.
Publicado: (2018) -
GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice
por: Kuberska, Karolina, et al.
Publicado: (2021) -
Antihypertensive Deprescribing in Older Adults: a Practical Guide
por: Sheppard, James P., et al.
Publicado: (2022) -
The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study
por: Sheppard, James P., et al.
Publicado: (2023)